• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    CEO and President Sim Brandon was granted 145,642 shares and covered exercise/tax liability with 105,795 shares, increasing direct ownership by 4% to 1,023,219 units (SEC Form 4)

    3/7/25 8:59:38 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Sim Brandon

    (Last) (First) (Middle)
    C/O ASTRANA HEALTH, INC.
    1668 S. GARFIELD AVENUE, 2ND FLOOR

    (Street)
    ALHAMBRA CA 91801

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Astrana Health, Inc. [ ASTH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    CEO and President
    3. Date of Earliest Transaction (Month/Day/Year)
    03/05/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/05/2025 A 145,642(3) A $0 1,129,014 D
    Common Stock 03/05/2025 F 105,795(4) D $27.19 1,023,219(5)(6) D
    Common Stock 258,824 I By Sim Family Irrevocable Trust 2021(1)
    Common Stock 392,816 I By Brandon Sim 2020 Irrevocable Trust(2)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. These securities are held by the Sim Family Irrevocable Trust 2021. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
    2. These securities are held by the Brandon Sim 2020 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
    3. Represents a grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in eight equal semi-annual installments beginning on September 5, 2025.
    4. Represents the surrender of shares to offset against tax withholding obligations associated with the vesting of certain shares of restricted stock.
    5. Includes the following shares of unvested restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 59,837 shares, which will vest in two equal annual installments on June 27, 2025 and 2026; and (ii) 85,513 shares, which will vest in five equal semi-annual installments, beginning March 31, 2025. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 105,605 restricted stock units, which will vest in seven equal semi-annual installments beginning on April 2, 2025; and (ii) 145,642 restricted stock units, which will vest in eight equal semi-annual installments beginning on September 5, 2025.
    6. Includes 644 shares acquired under the Issuer's Employee Stock Purchase Plan.
    /s/ Kathy Diep, as Attorney-in-Fact 03/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ASTH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    Financials

    Live finance-specific insights

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

      Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024. "Astrana Health's strong performance in 2024 highlights the s

      2/27/25 4:27:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    SEC Filings

    See more
    • Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/13/25 4:15:50 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Astrana Health Inc.

      10-Q - Astrana Health, Inc. (0001083446) (Filer)

      5/9/25 5:02:17 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/8/25 4:15:57 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. to Participate in Upcoming Investor Conference

      ALHAMBRA, Calif., April 24, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO, and Chan Basho, CFO and COO, are participating in the BofA Securities 2025 Health Care Conference, being held in Las Vegas, on Tuesday, May 13, 2025, including a fireside chat at 3:00pm PT. The webcast link will be available in the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-c

      4/24/25 8:30:00 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • COO and CFO Basho Chandan covered exercise/tax liability with 10,035 shares, decreasing direct ownership by 5% to 178,640 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      5/19/25 6:12:01 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 828 shares, decreasing direct ownership by 0.36% to 227,298 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/30/25 8:44:02 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • COO and CFO Basho Chandan covered exercise/tax liability with 2,683 shares, decreasing direct ownership by 1% to 188,675 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/16/25 4:15:20 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Barclays initiated coverage on Astrana Health with a new price target

      Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

      4/1/25 7:41:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • TD Cowen initiated coverage on Astrana Health with a new price target

      TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

      10/14/24 7:24:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • KeyBanc Capital Markets initiated coverage on Astrana Health

      KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

      10/11/24 7:36:28 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary